Watson Pharma said they will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.

The combination with Arrow will result in a global pharmaceutical company with more than $3 billion in revenue and operations in more than 20 countries, Watson said. Arrow generated $647 million in revenue last year, and has had a 67% organic compound annual growth rate since 2001, Watson said. The company was founded in 2000.

I hope they will have diet pills that work.